ENTA as of Oct 30 · 23:54 ET
ENTANasdaqPharmaceutical Preparations
Enanta Pharmaceuticals Inc · Brief
Next report
16 days
Nov 16 · after closeest.Q4 FY26
Expected move
Inputs0 of 8≥ implied
- avg implied
- ±17.0%
- avg realized
- ±5.6%
Nov 25 '24±12.3%▼−4.99%×0.40
Feb 10 '25±20.3%▲+14.08%×0.69
May 12 '25±14.5%▼−5.77%×0.40
Aug 11 '25±20.5%▲+5.70%×0.28
Nov 17 '25±17.1%▼−3.59%×0.21
Q1 FY26±13.1%▲+2.17%×0.17
Q2 FY26±19.0%▼−6.02%×0.32
Q3 FY26±19.1%▼−2.10%×0.11
quarterimplied−25%0+25%realized×
Q3 FY26±19.1%▼−2.10%×0.11
Q2 FY26±19.0%▼−6.02%×0.32
Q1 FY26±13.1%▲+2.17%×0.17
Nov '25±17.1%▼−3.59%×0.21
Aug '25±20.5%▲+5.70%×0.28
May '25±14.5%▼−5.77%×0.40
2 older reports
Feb '25±20.3%▲+14.08%×0.69
Nov '24±12.3%▼−4.99%×0.40
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 16 report · est.Bull2
+8.76%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
ENTA report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.